Israel Englander Vaxxinity, Inc. Transaction History

Millennium Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.62 - $0.86 $3,289 - $4,563	5,306 Added 12.37%	48,194 $34,000
Q4 2023 Feb 14, 2024	BUY	$0.7 - $1.31 $20,213 - $37,827	28,876 Added 206.08%	42,888 $36,000
Q2 2023 Aug 14, 2023	SELL	$1.73 - $2.79 $393,012 - $633,818	-227,175 Reduced 94.19%	14,012 $35,000
Q1 2023 May 15, 2023	BUY	$1.43 - $4.24 $241,355 - $715,627	168,780 Added 233.1%	241,187 $547,000
Q4 2022 Feb 14, 2023	BUY	$1.31 - $2.62 $73,679 - $147,359	56,244 Added 347.98%	72,407 $101,000
Q3 2022 Nov 14, 2022	SELL	$1.64 - $2.48 $323,829 - $489,693	-197,457 Reduced 92.43%	16,163 $32,000

198K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.